secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001493152-25-016200
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology announces $2.25M private placement of stock and warrants
---------------------------------------------------------------------------

- Gross proceeds ~$2.25M from sale of 1,733,766 shares at $1.30; one warrant per share at $1.57 exercise price.
- Funds will support Step 1 of Part C of Phase II trial THIO-101 and working capital.
- Greater than 5% holder FGMK subscribed for 769,230 shares & warrants for ~$1M; director Stan Smith for 19,230 shares.
- Existing warrants for 1,396,667 shares amended to reduce exercise price from $1.87 to $1.30.
- Closing expected on or about October 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225016200/0001493152-25-016200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225016200/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-016200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer